Are A2 Milk shares a buy after the 10% selloff on Monday?

This infant formula company's shares sank deep into the red on Monday. Let's see what a leading broker is saying.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A2 Milk Company Ltd (ASX: A2M) shares started the week with a heavy decline.

On Monday, the infant formula company's shares crashed 10% to $6.55 after announcing a product recall in the United States.

This latest decline means that its shares are now down almost 30% since the start of the year.

Let's see if Bell Potter thinks this has created a buying opportunity for investors.

Two people comparing and analysing material.

Image source: Getty Images

What is the broker saying?

Bell Potter suspects that contaminated ARA could be behind the product recall. It said:

A2M has initiated a voluntary recall of three batches of IMF products sold in the USA due to the presence of cereulide, with the probable source from an ingredient in the IMF supply chain. The ingredient hasn't been named but we note contaminated ARA has been the product causing similar cereulide contamination recalls globally from competitor products and as such we suspect this is the likely culprit. The recall covers a small amount of volume and hence is not expected to have an impact on FY26e outcomes.

However, the broker does see risks that the news could impact its brand in the lucrative China market. It adds:

There is the risk that A2 as a brand in China could be associated with a contaminated product and that can have an impact on the perception of the brand in China, even if the recall is outside China and the recall volume is small. A formal announcement by GACC has been released, stating that the recalled product was only sold in the USA, which likely further brings attention to the event.

Bell Potter suspects that this could lead to a higher marketing investment to recapture lost customers. The broker said:

We note our forecasts were below consensus in FY27e, as we had expected the issues in 4Q26e COGS would drag into 1Q27e and had seen the potential for marketing investment to be front ended as A2M would need to recapture lost customers. There is the potential that brand investment will need to be lifted as A2M seeks to reassure Chinese customers over product safety.

Should you buy A2 Milk shares after the dip?

According to the note, Bell Potter has retained its hold rating on A2 Milk shares with a reduced price target of $6.75 (from $8.35). This compares to its current share price of $6.55.

Commenting on its recommendation, the broker said:

Our Hold rating is unchanged. Product recalls, even outside of China have the scope to impact brand perception. The timing of the recall is also less than ideal as A2M is already short product on ground in China and hence already needed to potentially invest to recapture customers that had switched to alternative suppliers.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Xero and Northern Star shares

A leading expert forecasts ongoing headwinds for Xero and Northern Star shares. But why?

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Up 118%! Are PLS shares now a buy, hold or sell?

A leading expert provides his outlook for PLS' surging shares.

Read more »

Happy investor on tablet with finance graphs rising in overlay.
Broker Notes

Buy, hold, sell: ANZ Bank, Iress, and JB Hi-Fi shares

Here's what Morgans thinks of these shares following recent updates.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.
Broker Notes

Is the CSL share price in the buy zone after the biotech giant's results?

Is the biotech giant a buy following its results release?

Read more »

ASX 200 bank share trading depicted by red buy and sell dice tumbling across a sheet of data in colourful graphics
Broker Notes

With $30 billion in FY26 income, should I buy CBA shares today?

A leading analyst digs into the outlook for CBA’s slipping shares.

Read more »

Woman and man calculating a dividend yield.
Broker Notes

Buy, hold, sell: REA, Northern Star Resources, Suncorp shares

Two experts share their views on three ASX 200 shares.

Read more »

Two female executives looking at a clipboard together.
Broker Notes

Buy, hold, sell: Centuria Industrial REIT, Endeavour, Wildcat Resources shares

Experts share their views on the lithium miner, hotels operator, and industrial ASX REIT.

Read more »

A group of five engineers wearing hard hats and some in high visibility vests raise their arms in happy celebration atop a building site with construction and equipment in the background.
Broker Notes

Why this $1.4 billion ASX All Ords mining stock is tipped to jump 30%

A top wealth manager forecasts more than 30% returns from this ASX mining stock.

Read more »